NPR recently ran a story that suggests terminally ill patients can safely stop taking cholesterol-reducing statin drugs. The final quote of the article is illuminating: “Most of the studies focus on when to start a medication; there’s been very little focus on when do you stop it.” No surprise there: whether you’re very young or very old, Big Pharma would love you to continue buying statins—for a very long time indeed.
Heart disease, as many of us know, is one of the leading causes of death in the US, killing about 610,000 people each year. Big Pharma—in the belief that cholesterol is the primary factor in heart disease—developed statin drugs that would lower cholesterol and reduce the risk of heart disease. The drugs, which have been accompanied by massive marketing campaigns, are huge moneymakers for the drug industry, to the tune of about $29 billion worth of sales in 2013. That’s the kind of outrageous money you make when you convince one in four Americans over the age of 45 to take statins.
Over the years we’ve reported on a wide range of negative health effects that have been linked to these drugs. Here is a survey of some of these findings:
Even when it comes to heart disease prevention, conventional thinking gets it wrong. The American Heart Association, for instance, published a study based on the outdated, simplistic notion that there are two kinds of cholesterol: “bad” (LDL) and “good” (HDL). The AHA’s dietary guidelines are also centered on the debunked notion that “bad” cholesterol causes heart disease, and that since saturated fat may raise “bad” cholesterol levels, it’s the ultimate dietary evildoer. And here’s the kicker: the AHA’s guidelines could lead to 33 million healthy Americans taking statins.
What the AHA does not seem to understand is that cholesterol is vital to human health. We’ve noted in the past that cholesterol isn’t the ticking time bomb most people have been led to think—in fact, the real danger is that our cholesterol levels can get too low as we age! Even “bad” cholesterol is essential.
- Harlan Krumholz of Yale’s Department of Cardiovascular Medicine found that old people with low cholesterol died twice as often from a heart attack as did old people with high cholesterol.
- A review of nineteen large studies of more than 68,000 deaths by the Division of Epidemiology at the University of Minnesota found that low cholesterol predicted an increased risk of dying from gastrointestinal and respiratory diseases.Another study of almost 15,000 patients over 18 years found that those with higher LDL levels and total cholesterol had a lower risk of developing atrial fibrillation, an irregular heart rate that causes poor blood flow to the body.
- A review article published in 2005 by a Japanese scientist found that “high total cholesterol is not positively associated with coronary heart disease mortality rates among general populations more than 40–50 years of age,” and therefore there is little benefit to lowering cholesterol levels if you’re older.
- A 2005 study from the Columbia University College of Physicians and Surgeons found that people with the lowest cholesterol and LDL levels were twice as likely to die within three years compared to those with the highest levels.
While it is now clear from the science that cholesterol is not the demon behind heart disease, it’s equally clear that poor eating habits, lack of exercise, and obesity are direct causes. The good news is that heart disease can be entirely reversed through diet! In a recent article, Dr. Joseph Mercola stated that the Paleo diet can be very effective in reducing blood pressure and triglyceride levels—more effective, actually, than any statin drug. In addition, Dr. Mercola recommends aketogenic diet, which actually increases fat intake, albeit using healthy fats.
These kinds of integrative approaches to health and prevention, however, stand in the way of one of Big Pharma’s largest cash cows, so it’s no wonder we don’t see them (or the scientific studies that show how dangerous statin drugs are) more widely publicized. Watch these pages over the next couple of weeks for our follow-up article on alternatives to statins.